Lundbeck has appointed João Rocha and Michael Quiqueran-Beaujeu as regional vice presidents for European markets. The Danish firm says these appointments will play an important role in strengthening the company’s organisation in the region at a time when it will be launching a number of drugs.
Lundbeck is dividing its European markets into West and East regions. Rocha will take responsibility for commercial activities in a majority of the Western European countries as regional vice president for the West region, while Quiqueran-Beaujeu will lead Lundbeck’s activities in Eastern Europe as well as Turkey and Russia.
Michael Quiqueran-Beaujeu
Rocha was previously Lundbeck’s country manager in Brazil and regional vice president for Latin America. He turned the antidepressant Lexapro into Brazil’s eighth best-selling drug, and positioned Lundbeck as a central player in the Latin American pharmaceutical industry. Before joining Lundbeck, Rocha worked for US pharmaceutical companies Schering-Plough and Merck.
Quiqueran-Beaujeu comes to Lundbeck from Genzyme, where he was senior vice president and general manager for Northern Europe.
